Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenapanor in IBS-C (T3MPO-2)
NCT02686138Phase 3Completed
- Sponsor
- Ardelyx
- Start
- Dec 2015
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenapanor in irritable bowel syndrome (IBS), sponsored by Ardelyx. Started Dec 2015; status: completed.
02
Drugs
tenapanor
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02686138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02686138.